CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 1 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $21,910,000 | 12.73% |
| venBio Partners LLC | 3,673,374 | $53,595,000 | 4.73% |
| Sofinnova Investments, Inc. | 3,606,707 | $52,622,000 | 3.13% |
| Omega Fund Management, LLC | 1,335,050 | $19,478,000 | 2.92% |
| CLOUGH CAPITAL PARTNERS L P | 1,332,397 | $19,353,000 | 1.38% |
| Novo Holdings A/S | 2,170,100 | $31,662,000 | 1.36% |
| SECTORAL ASSET MANAGEMENT INC | 548,802 | $8,007,000 | 0.56% |
| Ensign Peak Advisors, Inc | 119,915 | $1,750,000 | 0.00% |
| DEUTSCHE BANK AG\ | 203,534 | $2,970,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,326 | $19,000 | 0.00% |